AbbVie Inc. is 236.2x more valuable than Innoviva, Inc. by market capitalization ($399.47 B vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INVA | ABBV |
|---|---|---|
| Market cap | $1.69 B | $399.47 B |
| US-listed rank | #2233 | #28 |
| Revenue (latest FY) | $411.33M | $61.16B |
| Net income (latest FY) | - | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 1,653 | 1,008 |
AbbVie Inc. is 236.2x more valuable than Innoviva, Inc. by market capitalization ($399.47 B vs $1.69 B).
In their latest fiscal years, Innoviva, Inc. reported $411.33M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Innoviva, Inc. and AbbVie Inc., or browse the full rankings.